Curanol

Description

CuraNOL is a topical formulation intended for external use only. The active ingredient is not specified in the provided information. The product is packaged in a specific container, although details regarding the container are not included. Inactive ingredients are also not listed in the available data.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with various conditions, including headache, backache, muscular aches, minor pain of arthritis, the common cold, toothache, and premenstrual and menstrual cramps. Additionally, it is indicated for the temporary reduction of fever.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Dosage may be repeated every 4 hours, or as directed by a healthcare professional. It is imperative not to exceed the recommended dose. The appropriate dosage should be determined using the chart provided below; if possible, weight should be used for dosing, otherwise age may be utilized.

Dosage Chart

Weight (lbs)

• Under 24: Consult a doctor

• 24-35: 1 teaspoon (5 mL)

• 36-47: 1 1/2 teaspoons (7.5 mL)

• 48-59: 2 teaspoons (10 mL)

• 60-71: 2 1/2 teaspoons (12.5 mL)

• 72-95: 3 teaspoons (15 mL)

• Over 95: 4 teaspoons (20 mL)

Age (years)

• Under 2: Consult a doctor

• 2 to 3: 1 teaspoon (5 mL)

• 4 to 5: 1 1/2 teaspoons (7.5 mL)

• 6 to 8: 2 teaspoons (10 mL)

• 9 to 10: 2 1/2 teaspoons (12.5 mL)

• 11: 3 teaspoons (15 mL)

• 12 to Adult: 4 teaspoons (20 mL)

Healthcare professionals should ensure that the dosage is appropriate for the patient's specific circumstances and monitor for any adverse effects.

Contraindications

There are no contraindications associated with the use of this product. It is deemed safe for use in the absence of specific conditions or situations that would warrant avoidance.

Warnings and Precautions

This product contains acetaminophen, which poses a significant risk of severe liver damage under certain conditions. Adults should not exceed 6 doses within a 24-hour period, while children must not take more than 5 doses in the same timeframe. The risk of liver damage increases if acetaminophen is taken concurrently with other medications containing acetaminophen, whether prescription or nonprescription. Additionally, adults consuming 3 or more alcoholic beverages while using this product are at heightened risk for liver injury.

Acetaminophen may also trigger severe skin reactions, which can manifest as skin reddening, blisters, or rash. In the event of any skin reaction, it is imperative to discontinue use immediately and seek medical assistance. To avoid the risk of overdose, this product should not be used in conjunction with any other medications containing acetaminophen. Healthcare professionals should advise patients to consult a doctor or pharmacist if there is uncertainty regarding the presence of acetaminophen in other medications.

When utilizing this product, it is crucial to adhere strictly to the recommended dosage. Patients with a history of liver disease should consult a healthcare provider prior to use. Furthermore, individuals taking the anticoagulant warfarin should seek guidance from a doctor or pharmacist before using this product.

Patients are advised to discontinue use and contact their healthcare provider if any of the following occur: pain worsens or persists beyond 10 days in adults, pain lasts more than 5 days in children under 12 years, fever worsens or continues for more than 3 days, new symptoms arise, or if redness or swelling is observed, as these may indicate a serious underlying condition.

In cases of skin reactions, immediate emergency medical assistance is warranted.

Side Effects

Severe liver damage may occur in patients taking this product containing acetaminophen if they exceed the recommended dosage. Specifically, adults should not take more than 6 doses in a 24-hour period, while children should not exceed 5 doses within the same timeframe. The risk of liver damage is further heightened if this product is used concurrently with other medications containing acetaminophen, whether prescription or nonprescription. Additionally, adults consuming 3 or more alcoholic drinks while using this product are at an increased risk for severe liver damage.

Patients should also be aware of the potential for severe skin reactions associated with acetaminophen. Symptoms of such reactions may include skin reddening, blisters, and rash. In the event of a skin reaction, patients are advised to discontinue use immediately and seek medical assistance.

Drug Interactions

Patients should consult a healthcare professional prior to using this medication if they are concurrently taking warfarin, a blood-thinning agent. The combination may necessitate careful monitoring due to potential interactions that could affect anticoagulation levels.

Additionally, this medication should not be used in conjunction with any other products containing acetaminophen, whether prescription or nonprescription. Co-administration may lead to an excessive intake of acetaminophen, resulting in overdose and serious health risks. It is essential to adhere to the recommended dosage guidelines to avoid such complications.

Packaging & NDC

Below are the non-prescription pack sizes of Curanol (acetaminophen). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients may receive the medication every 4 hours as needed, but the total daily dosage must not exceed the recommended limits. Dosing should ideally be based on weight; however, age can be used as an alternative if weight information is unavailable.

The following dosage chart provides guidance for pediatric patients:

• For patients weighing under 24 lbs (under 2 years): 1 tsp (5 mL)

• For patients weighing 24-35 lbs (ages 2 to 3 years): 1 1/2 tsp (7.5 mL)

• For patients weighing 36-47 lbs (ages 4 to 5 years): 2 tsp (10 mL)

• For patients weighing 48-59 lbs (ages 6 to 8 years): 2 1/2 tsp (12.5 mL)

• For patients weighing 60-71 lbs (ages 9 to 10 years): 3 tsp (15 mL)

• For patients weighing 72-95 lbs (age 11 years): 4 tsp (20 mL)

• For patients weighing over 95 lbs (ages 12 years to adult): Consultation with a doctor is recommended.

Healthcare professionals should advise caregivers to discontinue use and seek medical advice if a child's pain worsens or persists for more than 5 days, particularly in children under 12 years of age.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is important to assess the potential risks and benefits, as well as any available data regarding fetal outcomes and lactation. Healthcare providers can offer guidance tailored to individual circumstances, ensuring the safety of both the patient and the developing fetus or nursing infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring of these patients.

Hepatic Impairment

Patients with hepatic impairment should be aware that this product contains acetaminophen, which carries a risk of severe liver damage. It is critical that adults do not exceed 6 doses within a 24-hour period, as this is the maximum daily amount. For children, the maximum daily amount is 5 doses within the same timeframe.

Additionally, patients must avoid taking this product in conjunction with other medications that contain acetaminophen, whether prescription or nonprescription, as this can further increase the risk of liver damage. Consumption of 3 or more alcoholic drinks while using this product is also contraindicated for adults, as it may exacerbate the potential for severe liver injury.

Patients with a known history of liver disease are advised to consult a healthcare professional prior to using this product to ensure safety and appropriate management of their condition. Regular monitoring of liver function may be warranted in these individuals to prevent adverse effects.

Overdosage

Severe liver damage may occur in cases of overdosage, particularly under the following circumstances:

Dosage Limits Adults should not exceed 6 doses within a 24-hour period, as this represents the maximum daily amount. For children, the maximum is 5 doses in the same timeframe. Exceeding these limits significantly increases the risk of liver injury.

Drug Interactions The concomitant use of this product with other medications containing acetaminophen, whether prescription or nonprescription, is contraindicated. Such combinations can lead to an intake that surpasses the recommended dosage of acetaminophen, resulting in serious health complications.

Alcohol Consumption In adults, the consumption of 3 or more alcoholic beverages while using this product can exacerbate the risk of liver damage. It is crucial to avoid alcohol to mitigate this risk.

Recommended Actions Healthcare professionals are advised to monitor patients for symptoms of liver damage, which may include jaundice, dark urine, fatigue, and abdominal pain. In the event of suspected overdosage, immediate medical attention should be sought. It is imperative to adhere strictly to the recommended dosage guidelines to prevent potential overdose and its associated health risks.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

Acetaminophen has been associated with severe skin reactions reported in postmarketing surveillance. Symptoms of these reactions may include skin reddening, blisters, and rash. In the event of a skin reaction, it is advised to discontinue use immediately and seek medical assistance.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion or misuse. It is important to emphasize the necessity of proper storage to ensure the safety of young individuals.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain integrity. It should be stored at a temperature range of 20°C to 25°C (68°F to 77°F), with permissible excursions between 15°C to 30°C (59°F to 86°F). It is essential to protect the product from light to prevent degradation. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

The medication is administered orally. Clinicians should advise patients who are pregnant or breastfeeding to consult a health professional prior to use. No further information is available regarding laboratory tests, abuse potential, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Curanol, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)